Nevertheless, the limited available studies consequently report on the increase of HER2 positive breast cancer cases raining from to 1.4% to 7.3%using the 2013 ASCO/CAP guidelines [8–11, 14]. The gene discussed is ERBB2; the disease is breast carcinoma.